← Back to headlines
Tarsus Pharmaceuticals Expands into Retina Market with iRenix Deal
Tarsus Pharmaceuticals has entered the retina market through a new deal involving iRenix, thereby adding IRX-101 to its development pipeline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
